SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The filing explicitly discloses a non-cash impairment loss of approximately $18 million for BXP, Inc. and $17 million for BPLP in Q2 2026, resulting from the sale of the Sumner Square property at a price below its carrying value. The impairment is quantified and expected to reduce diluted EPS by $0.10 per share, making it material to investors' assessment of the company's financial condition.
View raw filing on EDGAR →Encore Capital Group issued €325.0 million in senior secured floating rate notes due 2033 pursuant to a definitive indenture agreement. This material debt financing, with senior secured status and guarantees from material subsidiaries, affects the company's capital structure and financial obligations.
View raw filing on EDGAR →FG Merger II Corp. entered into a material definitive Forward Purchase Agreement with Atsion Opportunity Fund LLC and FG Capital Partners, LLC on May 28, 2026, in connection with its proposed business combination with BOXABL Inc. This is disclosed under Item 1.01 (Entry Into A Material Definitive Agreement) and represents a financing arrangement tied directly to the SPAC merger transaction. The agreement provides for up to 3,000,000 shares of common stock and includes prepayment and settlement mechanisms contingent on the Business Combination closing, making it a material ancillary transaction to the M&A activity.
View raw filing on EDGAR →The disclosure announces a resubmission of a Biologics License Application (BLA) for RP1 in combination with nivolumab following FDA communications. This represents a material regulatory development for a clinical-stage biopharmaceutical company, as BLA resubmission decisions directly impact the path to commercialization and investor valuation. While not a traditional earnings release, exec change, or M&A event, the regulatory milestone is material to investors assessing the company's pipeline progress and FDA approval prospects.
View raw filing on EDGAR →Ivanhoe Electric entered into a material definitive purchase agreement with Robbins on May 28, 2026, to acquire a Tunnel Boring Machine and associated equipment for the Santa Cruz Copper Project at a total cost of approximately $70.5 million ($64.7 million for the TBM plus $5.8 million for assembly). This constitutes a material acquisition of equipment essential to the company's mining operations, with significant financial commitment and detailed contractual terms governing delivery, commissioning, and performance obligations through July 2027.
View raw filing on EDGAR →El Pollo Loco held its Annual Meeting on May 26, 2026, with shareholders voting on six proposals including director elections (Tana Davila and Frank Garrido), auditor ratification (BDO USA, P.C.), say-on-pay and say-on-frequency advisory votes, equity plan amendments increasing the share pool by 1,250,000 shares, and a shareholder proposal on majority voting. The Board committed to holding annual advisory votes on executive compensation based on the voting results.
View raw filing on EDGAR →Vireo Growth subsidiary entered into a definitive agreement to acquire a 389,000 square foot cannabis cultivation facility from an Innovative Industrial Properties subsidiary for $88.5 million, funded through a combination of cash and seller financing ($49M seller note and $41M Chicago Atlantic loan), representing a material acquisition of tangible assets and operational capacity.
View raw filing on EDGAR →NCLC elected to fix the settlement method to cash-only for its exchangeable senior notes (1.125% and 2.50% due 2027), eliminating the possibility of physical share settlement. While this reduces future dilution by approximately 2–4 million shares, the core event is the irrevocable election to settle in cash rather than shares, which is a material modification to the terms of dilutive securities. The disclosure centers on the settlement method change and its quantified impact on share count guidance, making it most closely aligned with dilutive_issuance, though the direction of impact (reduction in dilution) is atypical for that category.
View raw filing on EDGAR →The filing discloses a $5 billion debt offering completed on May 29, 2026, with explicit stated purpose to "fund the acquisition of Frigeo Holdings LLC ('CoolIT Systems')" and references the underlying "Agreement and Plan of Merger, dated as of March 20, 2026." While the debt issuance itself is the immediate event, the material substance is financing for a material acquisition. The special mandatory redemption provisions tied to the CoolIT Systems Acquisition completion further confirm the acquisition is the central material event driving this disclosure.
View raw filing on EDGAR →The filing discloses a press release announcing the Trust's "monthly net profits interest calculations" under Item 2.02 (Results of Operations and Financial Condition). This is a periodic financial results disclosure characteristic of an earnings release, even though it is monthly rather than quarterly or annual. For a trust structure like Pacific Coast Oil Trust, monthly profit distributions are a core material metric that investors rely on to assess performance and cash distributions.
View raw filing on EDGAR →Runway Growth Finance Corp. entered into an underwriting agreement on May 27, 2026, and a Fourth Supplemental Indenture on May 29, 2026, to issue $50 million in 7.00% Notes due 2029. The transaction closed on May 29, 2026, with proceeds to be used for repayment of existing indebtedness and general corporate purposes.
View raw filing on EDGAR →NCL Corporation elected to fix the settlement method to cash (rather than physical share delivery) for exchangeable senior notes due 2027. While this is technically an anti-dilutive action—reducing expected share dilution by approximately 2-4 million shares—the filing discloses a material change to the terms of previously issued convertible/exchangeable securities. The event centers on the company's management of dilution from existing convertible debt instruments, which falls within the dilutive_issuance taxonomy as it concerns the mechanics and impact of equity-linked securities on share count.
View raw filing on EDGAR →Avalanche Treasury Corp entered into a Master Lender Agreement and a $25 million collateralized loan term sheet with FalconX Charlie, Inc., with proceeds designated to finance closing costs for the pending business combination between AVAT and Mountain Lake Acquisition Corp.
View raw filing on EDGAR →The company disclosed financial results for the three months ended March 31, 2026, made available on May 29, 2026.
View raw filing on EDGAR →TopBuild disclosed its election to redeem $400 million of senior notes, conditioned upon stockholder approval of a proposed acquisition by QXO, Inc. under an Agreement and Plan of Merger dated April 18, 2026. While the Item 8.01 disclosure centers on the redemption mechanics, the material event is the pending merger transaction itself—the redemption is explicitly contingent on the "Approval Condition" (stockholder approval of the acquisition). The filing references the merger agreement and QXO's Form S-4 registration statement, confirming this is a material acquisition event that would affect investor assessment of TopBuild's future.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the results of International Tower Hill Mines' 2026 Annual General Meeting of Shareholders held on May 27, 2026, including voting outcomes for four proposals: election of seven directors (all elected with >50% support), ratification of auditors Davidson & Company LLP, advisory approval of named executive officer compensation, and shareholder preference for annual say-on-pay votes. The filing directly matches the shareholder_vote_results event type and is material as it documents formal shareholder actions on governance and compensation matters.
View raw filing on EDGAR →The filing discloses a registered direct offering of 8,539,709 shares of common stock to GMS Ventures and Investments pursuant to a securities purchase agreement dated May 28, 2026. This is a material equity issuance that dilutes existing shareholders and is typically a signal of capital-raising activity at smaller issuers. The transaction was conducted under an effective Form S-3 registration statement, making it a registered offering rather than an unregistered private placement, but it remains a material dilutive issuance requiring disclosure.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Monarch Casino & Resort's Annual Meeting of Stockholders held on May 27, 2026. The filing reports the outcomes of two proposals: (1) election of four directors (John Farahi, Craig F. Sullivan, Paul Andrews, and Hope S. Taitz) with detailed vote tallies, and (2) advisory approval of executive compensation. The tabular presentation of "For," "Against," "Abstain," and "Broker Non-Vote" votes is the standard format for Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →The filing discloses eXp World Holdings' participation in a settlement of putative class action litigation (Tuccori Action) following preliminary court approval on May 26, 2026. The Company entered into an Opt-In Settlement Agreement on April 14, 2026, and the settlement is expected to resolve claims with the same factual predicates as the Batton Action. This is a material litigation settlement that would affect investor assessment of the Company's legal and financial exposure.
View raw filing on EDGAR →This Item 5.07 discloses the results of TMC the Metals Company's Annual Meeting held on May 28, 2026, including voting outcomes on five matters: setting the board size at ten directors, election of all ten directors, appointment of Ernst & Young LLP as auditor, say-on-pay advisory vote approval, and say-on-frequency vote (with shareholders approving a two-year frequency). The detailed vote tallies and outcomes are the core disclosure required by Item 5.07.
View raw filing on EDGAR →Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of Cencora, Inc., effective June 29, 2026, succeeding retiring CFO James F. Cleary. The appointment includes compensatory arrangements including a $1,000,000 base salary, 100% annual bonus target, $2,000,000 sign-on bonus, and $6,000,000 RSU award.
View raw filing on EDGAR →The Company entered into an Amended and Restated Sales Agreement to conduct an at-the-market (ATM) offering of Class A common stock, increasing the maximum aggregate offering price from $92.8 million to $250 million. This is a dilutive equity issuance that would materially affect shareholder interests and the total mix of information available to investors, particularly given the substantial increase in authorized offering capacity and the company's prior sales of $24.7 million under the prior agreement.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on May 27, 2026, covering three proposals: election of seven directors, advisory vote on executive compensation, and ratification of Grant Thornton as independent auditors. The filing presents voting tallies for each matter, which is the quintessential content of Item 5.07 shareholder vote results disclosures and is material to investors assessing board composition and governance.
View raw filing on EDGAR →This disclosure describes a material acquisition/merger activity: Duke Energy Progress will merge into Duke Energy Carolinas to create a single electric utility, with Duke Energy Corporation contributing its 100% equity interest in Duke Energy Carolinas to Progress Energy. The transaction has received regulatory approvals from FERC (January 30, 2026), PSCSC (April 30, 2026), and NCUC (May 1, 2026), with a targeted effective date of January 1, 2027. This is a change of control and material combination of utilities that would significantly affect the registrant's operations and structure.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of FTAI Aviation's 2026 Annual General Meeting held on May 28, 2026, including: (1) election of three Class I directors with vote tallies for each nominee; (2) non-binding advisory vote on named executive officer compensation; and (3) ratification of KPMG LLP as independent auditor. The filing presents voting results in tabular form for each proposal, which is the core content of shareholder vote result disclosures.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of an annual stockholder meeting held on May 27, 2026, including voting outcomes for director elections (Proposal #1) and advisory compensation approval (Proposal #2). The filing presents vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, BROKER NON-VOTES) for each proposal, which is the standard format for shareholder vote results required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →The Company issued 45,586.975 Class I shares for $1,064,000 pursuant to capital drawdown notices to investors under subscription agreements. This is an unregistered sale of equity securities exempt under Section 4(a)(2) and Regulation D, representing a dilutive issuance to existing shareholders. The disclosure of the specific share count, aggregate offering price, and exemption basis is characteristic of Item 3.02 dilutive issuance reporting.
View raw filing on EDGAR →ACM Shanghai's board approved a proposal for an H Share Listing on the Hong Kong Stock Exchange, involving issuance of up to 7% of total issued share capital with potential 15% over-allotment. This constitutes a material capital-raising and structural transaction that would affect the company's capitalization and ownership structure. While subject to shareholder and regulatory approval, the board's approval of the offering plan and listing proposal represents a significant M&A-adjacent activity requiring disclosure under Item 8.01.
View raw filing on EDGAR →Nu Skin held its Annual Meeting of Stockholders on May 28, 2026, at which stockholders voted on four proposals: election of nine directors, advisory approval of executive compensation, approval of an Amended and Restated 2024 Omnibus Incentive Plan, and ratification of PricewaterhouseCoopers LLP as auditor. All four proposals passed with substantial majorities.
View raw filing on EDGAR →The filing discloses a material cybersecurity incident in section (b) whereby a third-party vendor experienced unauthorized access to sensitive personal information of certain Company customers. Although the Company states its own systems were not compromised and no misuse has occurred to date, the disclosure of the incident itself, notification obligations to customers, credit monitoring services, and explicit acknowledgment of potential legal, reputational, and financial risks in the forward-looking statements section establish this as a reportable cybersecurity event under Item 1.05 (required since 2023). The Company's own characterization of potential "legal, reputational, and financial risks" elevates this beyond a purely vendor-related matter.
View raw filing on EDGAR →The filing discloses shareholder vote results from an annual or special meeting, with incorporation of Item 5.02 content regarding the election of 11 directors to KKR's Board, including Henry R. Kravis and George R. Roberts. The substantive voting outcome is that all directors were re-elected, though the Item 5.07 section itself contains limited detail beyond signature blocks.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Shareholders held on May 29, 2026. The filing presents voting results for two matters: (1) election of Class I director James L. Hamilton with specific vote counts (38.5M for, 32M withheld, 31.8M broker non-votes), and (2) ratification of KPMG LLP as independent auditor (101.7M for, 405K against, 177K abstentions). Shareholder vote results are material to investors as they reflect governance outcomes and auditor selection.
View raw filing on EDGAR →This disclosure describes an amendment to a previously announced merger agreement between Lisata Therapeutics and Kuva Labs Inc., modifying the offer price per share from $5.00 plus a $1.00 CVR to $4.00 plus a CVR with up to $3.00 in contingent payments, and extending key transaction dates. This constitutes a material modification to an ongoing material acquisition transaction, directly affecting shareholder value and deal economics.
View raw filing on EDGAR →Momentus Inc. entered into a Securities Purchase Agreement on May 26, 2026, for a private placement of 2,173,420 shares of Class A common stock at $8.50 per share and 768,580 pre-funded warrants, raising approximately $25 million in gross proceeds. The pricing was announced on May 27, 2026.
View raw filing on EDGAR →The filing discloses a corporate rebranding (name change to "FocalTherics" and ticker change to "FOCL"), combined with a material operational restructuring—the classification of ESWL and Distribution segments as discontinued operations. While the ticker/name change alone might be routine, the discontinued operations announcement signals a significant strategic shift that would materially affect investor assessment of the company's ongoing business and financial trajectory. This combination of rebranding and segment discontinuation does not fit neatly into the more specific event categories and is best classified as other_material.
View raw filing on EDGAR →The disclosure announces Board approval of a quarterly cash dividend payable to shareholders, which is material to investors as it signals capital allocation policy and financial health. However, routine dividend announcements do not fit neatly into the standard 8-K taxonomy categories (earnings_release, exec_departure, etc.), making "other_material" the most appropriate classification for this shareholder-relevant financial event.
View raw filing on EDGAR →Edesa Biotech held an Annual Meeting of shareholders on which four proposals were voted: election of seven directors, advisory vote on executive compensation, approval of an amendment to the 2019 Equity Incentive Compensation Plan increasing available shares by 750,000 and eliminating annual per-participant option grant limits, and appointment of MNP LLP as auditors. All proposals passed with substantial majorities.
View raw filing on EDGAR →Adam Paul was appointed as an independent director effective May 22, 2026, expanding the Board from nine to ten members. The appointment includes compensatory arrangements of $45,000 per month plus $4,000 per day for commitments exceeding four hours.
View raw filing on EDGAR →The company formed a Special Committee to review strategic alternatives, including financing, recapitalization, equity issuance, asset sales, and debt restructuring, with Houlihan Lokey retained as financial advisor. This broad mandate signals potential material corporate changes that could affect the company's financial condition and strategic direction.
View raw filing on EDGAR →The filing discloses a one-for-eight reverse stock split and reduction in authorized shares from 150,000,000 to 18,750,000, approved by stockholders on May 19, 2026 and effective May 29, 2026. While this is a structural capital event that affects all shareholders proportionately and is material to investors (affecting share count, trading basis, and equity compensation plans), it does not fit neatly into the more specific event categories. Reverse stock splits are typically routine corporate actions undertaken to maintain listing compliance or improve stock price perception, and the disclosure emphasizes no change in percentage ownership or par value. This is classified as other_material rather than a more specific category because the taxonomy lacks a dedicated reverse-split classification.
View raw filing on EDGAR →The Company implemented a 1-for-10 reverse share split effective May 28, 2026, approved by shareholders on May 5, 2026, through an amendment to its Memorandum of Association filed with the Cayman Islands Companies Registry. In connection with this capital restructuring, warrant terms were materially modified, including a reduction in the number of shares issuable per warrant to 1/10th and a ten-fold increase in exercise price to $15,525.00, proportionally adjusting warrant holders' economic rights.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Rani Therapeutics' annual meeting held on May 28, 2026. The filing reports voting outcomes for two proposals: (1) election of seven director nominees, with vote tallies for each candidate (For/Withheld/Broker Non-Votes), and (2) ratification of CBIZ CPAs P.C. as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the composition of the board and auditor selection.
View raw filing on EDGAR →Heritage Insurance announced successful placement of its 2026-2027 catastrophe excess-of-loss reinsurance program for its three insurance subsidiaries. For an insurance holding company, securing reinsurance capacity is material to investors as it directly affects the company's ability to manage catastrophic risk exposure and maintain underwriting capacity. However, the disclosure is routine operational news rather than a discrete event type (M&A, covenant breach, impairment, etc.), warranting classification as other_material.
View raw filing on EDGAR →Peabody Energy announced the pricing of a $225 million private offering of Convertible Senior Notes due 2031 to qualified institutional buyers under Rule 144A. Convertible notes are inherently dilutive securities that can be converted into equity, representing a material capital-raising event that would affect investor assessment of share dilution and the company's financial structure.
View raw filing on EDGAR →Calavo Growers was acquired by Mission Produce in a two-step merger transaction, with shareholders receiving 0.9790 Mission Produce shares plus $14.85 cash per Calavo share (approximately 17.5 million Mission Produce shares and $265.9 million in cash in aggregate consideration). The merger resulted in a change of control, termination of Calavo's credit facility, delisting from Nasdaq, and cessation of shareholder rights in the independent company.
View raw filing on EDGAR →Mission Produce completed its acquisition of Calavo Growers through a two-step merger structure, with consideration of approximately 17.5 million Mission Produce shares and $265.9 million in cash. The transaction included debt financing, treatment of Calavo equity awards, and resulted in the delisting of Calavo's common stock from Nasdaq.
View raw filing on EDGAR →Kathleen Holmgren was appointed to the Board of Directors of Mission Produce effective as of the closing of the Mergers, filling a newly created Class III director seat with a term expiring in 2029.
View raw filing on EDGAR →Ashland entered into a Second Amended and Restated Credit Agreement on May 28, 2026, providing a $500 million five-year revolving credit facility. This material financing arrangement affects the company's capital structure and liquidity position.
View raw filing on EDGAR →Genesco Inc. issued a press release on May 29, 2026 announcing results of operations for the first fiscal quarter ended May 2, 2026, with exhibits including the press release and a slide presentation summarizing financial results. This is a standard quarterly earnings disclosure under Item 2.02, material to investors assessing the company's financial performance and condition.
View raw filing on EDGAR →CoStar Group entered into a Stock Purchase Agreement on May 28, 2026, to acquire Zonda for $800 million in cash, combining real estate data and software businesses in a material strategic transaction.
View raw filing on EDGAR →